K922991

Substantially Equivalent

ABBOTT TDX/TDXFLX AND TDXFLX THEOPHYLLINE

Applicant: Abbott Laboratories
Product code: LGS
Advisory panel: Clinical Toxicology
Date received: 1992-06-22
Decision date: 1992-08-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.